Gil Blum
Stock Analyst at Needham
(3.96)
# 571
Out of 5,148 analysts
415
Total ratings
41.43%
Success rate
14.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Maintains: Buy | $71 → $75 | $32.67 | +129.57% | 15 | Feb 26, 2026 | |
| RXRX Recursion Pharmaceuticals | Reiterates: Buy | $8 | $3.63 | +120.39% | 26 | Feb 26, 2026 | |
| ACLX Arcellx | Downgrades: Hold | n/a | $114.05 | - | 26 | Feb 23, 2026 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $80 → $82 | $60.77 | +34.94% | 28 | Feb 13, 2026 | |
| MREO Mereo BioPharma Group | Maintains: Buy | $5 → $3 | $0.40 | +654.72% | 21 | Jan 13, 2026 | |
| AUTL Autolus Therapeutics | Maintains: Buy | $11 → $10 | $1.67 | +498.80% | 34 | Jan 12, 2026 | |
| GERN Geron | Reiterates: Buy | $5 | $1.55 | +222.58% | 23 | May 2, 2024 | |
| SLDB Solid Biosciences | Reiterates: Buy | $16 | $6.20 | +158.06% | 3 | Feb 9, 2026 | |
| NRIX Nurix Therapeutics | Reiterates: Buy | $26 | $15.81 | +64.45% | 29 | Jan 29, 2026 | |
| RNAC Cartesian Therapeutics | Maintains: Buy | $40 → $42 | $7.60 | +452.63% | 16 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $14.36 | - | 8 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.80 | +150.00% | 7 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $6 | $1.05 | +471.43% | 8 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.50 | - | 9 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $108.30 | -35.36% | 21 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $4.53 | +120.75% | 31 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $5.77 | +211.96% | 7 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.70 | +270.37% | 18 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | n/a | $16.32 | - | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | n/a | $4.97 | - | 22 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $4.00 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $12.52 | +283.39% | 9 | Aug 2, 2024 |
Immunocore Holdings
Feb 26, 2026
Maintains: Buy
Price Target: $71 → $75
Current: $32.67
Upside: +129.57%
Recursion Pharmaceuticals
Feb 26, 2026
Reiterates: Buy
Price Target: $8
Current: $3.63
Upside: +120.39%
Arcellx
Feb 23, 2026
Downgrades: Hold
Price Target: n/a
Current: $114.05
Upside: -
CRISPR Therapeutics AG
Feb 13, 2026
Maintains: Buy
Price Target: $80 → $82
Current: $60.77
Upside: +34.94%
Mereo BioPharma Group
Jan 13, 2026
Maintains: Buy
Price Target: $5 → $3
Current: $0.40
Upside: +654.72%
Autolus Therapeutics
Jan 12, 2026
Maintains: Buy
Price Target: $11 → $10
Current: $1.67
Upside: +498.80%
Geron
May 2, 2024
Reiterates: Buy
Price Target: $5
Current: $1.55
Upside: +222.58%
Solid Biosciences
Feb 9, 2026
Reiterates: Buy
Price Target: $16
Current: $6.20
Upside: +158.06%
Nurix Therapeutics
Jan 29, 2026
Reiterates: Buy
Price Target: $26
Current: $15.81
Upside: +64.45%
Cartesian Therapeutics
Jan 9, 2026
Maintains: Buy
Price Target: $40 → $42
Current: $7.60
Upside: +452.63%
Dec 19, 2025
Downgrades: Hold
Price Target: n/a
Current: $14.36
Upside: -
Dec 12, 2025
Reiterates: Buy
Price Target: $7
Current: $2.80
Upside: +150.00%
Nov 4, 2025
Maintains: Buy
Price Target: $9 → $6
Current: $1.05
Upside: +471.43%
Oct 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.50
Upside: -
Oct 20, 2025
Reiterates: Buy
Price Target: $70
Current: $108.30
Upside: -35.36%
Oct 17, 2025
Reiterates: Buy
Price Target: $10
Current: $4.53
Upside: +120.75%
Oct 17, 2025
Reiterates: Buy
Price Target: $18
Current: $5.77
Upside: +211.96%
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $2.70
Upside: +270.37%
Jul 29, 2025
Reiterates: Underperform
Price Target: n/a
Current: $16.32
Upside: -
Jul 24, 2025
Maintains: Hold
Price Target: n/a
Current: $4.97
Upside: -
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.00
Upside: -
Aug 2, 2024
Reiterates: Buy
Price Target: $48
Current: $12.52
Upside: +283.39%